Long-term outcomes with Boston type I keratoprosthesis in ocular burns

Resultados a longo prazo com a ceratoprótese de Boston tipo I em queimaduras oculares

Sérgio Kwitko About the author

Dear Editor,

We read with great interest the article entitled “Long-term outcomes with Boston type I keratoprosthesis in ocular burns”(11 Magalhães FP, Hirai FE, Sousa LB, Oliveira LA. Long-term outcomes with Boston type 1 keratoprosthesis in ocular burns. Arq Bras Oftalmol. 2018;81(3):177-82.), in which the results of Boston K-Pro in 12 eyes was evaluated. The authors concluded that type I Boston KPro “is a continuous thread that may result in irreversible visual loss in this population.” The potential long-term complications of K-Pro are actually sight-threatening and sometimes irreversible, as reported by several studies, including one by our group(22 Lansini T, Kwitko S. Quality of Life in Patients with Dohlman-Doane Type 1 Keratoprosthesis (Boston Kpro). J Clin Exp Ophthalmol. 2015;6:4. Doi: 10.4172/2155-9570.1000447.
https://doi.org/10.4172/2155-9570.100044...
), which found that the retention rate was 85.71% in 33 eyes during a mean follow-up period of 56.1 months, similar to the report by Magalhães’ et al. and with a similar complication rate. Nevertheless, we need to stress that, regardless of the risks of sight-threatening complications, these patients were blind, and after KPro implantation, their quality of life had improved significantly(11 Magalhães FP, Hirai FE, Sousa LB, Oliveira LA. Long-term outcomes with Boston type 1 keratoprosthesis in ocular burns. Arq Bras Oftalmol. 2018;81(3):177-82.). Therefore, even with the risks of serious complications, Boston type I KPro should be offered to these patients, with a complete understanding and acceptance of these potential risks of sight-threatening complications.

  • Funding: No specific financial support was available for this study.

REFERENCES

  • 1
    Magalhães FP, Hirai FE, Sousa LB, Oliveira LA. Long-term outcomes with Boston type 1 keratoprosthesis in ocular burns. Arq Bras Oftalmol. 2018;81(3):177-82.
  • 2
    Lansini T, Kwitko S. Quality of Life in Patients with Dohlman-Doane Type 1 Keratoprosthesis (Boston Kpro). J Clin Exp Ophthalmol. 2015;6:4. Doi: 10.4172/2155-9570.1000447.
    » https://doi.org/10.4172/2155-9570.1000447

Publication Dates

  • Publication in this collection
    16 May 2019
  • Date of issue
    May-Jun 2019

History

  • Received
    24 Jan 2019
  • Accepted
    29 Jan 2019

Response: long-term outcomes with Boston type 1 keratoprosthesis in ocular burns

Resposta: resultados a longo prazo com o implante da ceratoprótese de Boston tipo 1 em queimaduras oculares

Fernanda Pedreira Magalhães Flavio Eduardo Hirai Luciene Barbosa de Sousa Lauro Augusto de Oliveira About the authors Corresponding author: Fernanda Pedreira Magalhães. Av. Anita Garibaldi, 1477, Salas 211-212 - Salvador - BA - 40170-130 - Brazil E-mail: fernandapedreiramagalhaes@yahoo.com.br

Dear Editor,

We read with interest the comments about our article by Kwitko and associates. We agree with the authors that B-Kpro implantation is a valid option for visual rehabilita tion in patients with a severely damaged ocular surface se condary to ocular burns, as is clearly emphasized in the discussion section (first and last paragraphs below).

Discussion section:

First paragraph: “This study confirmed that B-Kpro implantation is a valid option for visual rehabilitation in patients with a severely damaged ocular surface secondary to ocular burns, and this finding is in agreement with findings of relevant studies.”

Last paragraph: “In summary, the anatomical and functional results in this study indicated the capability of B-Kpro for visual rehabilitation in patients with thermal or chemical ocular burns, who have experienced unsuccessful treatment for vision loss.”

While we understand the authors’ concern of irreversible visual loss in this population, their interpretation must be analyzed with discretion. We concluded that “type I Boston KPro is a continuous thread that may result in irreversible visual loss in this population” as referred in their letter. Our conclusion in the abstract section is: “The anatomical and functional results support the use of B-Kpro for managing bilateral limbal stem cell deficiency secondary to ocular burns. However, glaucoma should be carefully evaluated, as it is a continuous threat that may result in irreversible visual loss in this po pulation.” Even though this point was clear in the abstract (conclusion section), we would like to clarify that we had mentioned glaucoma as a continuous threat during follow-up of these patients as already pointed out by other authors(11 Cade F, Grosskreutz CL, Tauber A, Dohlman CH. Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis. Cornea. 2011;30(12):1322-7.).

REFERENCE

  • 1
    Cade F, Grosskreutz CL, Tauber A, Dohlman CH. Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis. Cornea. 2011;30(12):1322-7.
Conselho Brasileiro de Oftalmologia Rua Casa do Ator, 1117 - cj.21, 04546-004 São Paulo SP Brazil, Tel: 55 11 - 3266-4000, Fax: 55 11- 3171-0953 - São Paulo - SP - Brazil
E-mail: abo@cbo.com.br